203 related articles for article (PubMed ID: 33625720)
1. Dual-release hydrocortisone and its benefits on cognitive function and quality of sleep.
Krekeler C; Kropp P; Blacha AK; Rahvar AH; Harbeck B
Endocrine; 2021 Apr; 72(1):223-233. PubMed ID: 33625720
[TBL] [Abstract][Full Text] [Related]
2. Impaired attention in patients with adrenal insufficiency - Impact of unphysiological therapy.
Blacha AK; Rahvar AH; Flitsch J; van de Loo I; Kropp P; Harbeck B
Steroids; 2021 Mar; 167():108788. PubMed ID: 33412217
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
[TBL] [Abstract][Full Text] [Related]
4. Poor quality of life and sleep in patients with adrenal insufficiency-another cause of increased mortality?
Blacha AK; Kropp P; Rahvar AH; Flitsch J; van de Loo I; Harbeck B
Ir J Med Sci; 2022 Aug; 191(4):1653-1658. PubMed ID: 34389925
[TBL] [Abstract][Full Text] [Related]
5. Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients.
Delle Cese F; Corsello A; Cintoni M; Locantore P; Pontecorvi A; Corsello SM; Paragliola RM
Front Endocrinol (Lausanne); 2020; 11():610904. PubMed ID: 33597926
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Impact of Short- and Long-Term Hydrocortisone Replacement on Cognitive Function, Quality of Life and Catecholamine Secretion: A Pilot Study.
Harbeck B; Danneberg S; Rahvar AH; Haas CS; Lehnert H; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2016 Sep; 41(3):341-7. PubMed ID: 27170300
[TBL] [Abstract][Full Text] [Related]
7. Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency.
Gasco V; Giannelli J; Campioni L; Arvat E; Ghigo E; Grottoli S; Maccario M; Giordano R
J Endocrinol Invest; 2023 Mar; 46(3):587-597. PubMed ID: 36251244
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
Harbeck B; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
[TBL] [Abstract][Full Text] [Related]
9. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
[TBL] [Abstract][Full Text] [Related]
10. Improved salivary cortisol rhythm with dual-release hydrocortisone.
Ceccato F; Selmin E; Sabbadin C; Dalla Costa M; Antonelli G; Plebani M; Barbot M; Betterle C; Boscaro M; Scaroni C
Endocr Connect; 2018 Sep; 7(9):965-974. PubMed ID: 30300536
[TBL] [Abstract][Full Text] [Related]
11. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial.
Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BH; van Beek AP
Psychoneuroendocrinology; 2015 May; 55():36-47. PubMed ID: 25705800
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
Nilsson AG; Marelli C; Fitts D; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Lennernäs H; Skrtic S; Johannsson G
Eur J Endocrinol; 2014 Sep; 171(3):369-77. PubMed ID: 24944332
[TBL] [Abstract][Full Text] [Related]
13. Improved insulin sensitivity and secretion in prediabetic patients with adrenal insufficiency on dual-release hydrocortisone treatment: a 36-month retrospective analysis.
Guarnotta V; Ciresi A; Pillitteri G; Giordano C
Clin Endocrinol (Oxf); 2018 May; 88(5):665-672. PubMed ID: 29368442
[TBL] [Abstract][Full Text] [Related]
14. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
Castinetti F; Sahnoun M; Albarel F; Morange I; Philippon M; Conte-Devolx B; Brue T
Ann Endocrinol (Paris); 2015 Feb; 76(1):1-8. PubMed ID: 25617904
[TBL] [Abstract][Full Text] [Related]
15. Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study.
Guarnotta V; Mineo MI; Radellini S; Pizzolanti G; Giordano C
Ther Adv Endocrinol Metab; 2019; 10():2042018819871169. PubMed ID: 31489172
[TBL] [Abstract][Full Text] [Related]
16. Mild cognitive deficits in patients with primary adrenal insufficiency.
Tiemensma J; Andela CD; Biermasz NR; Romijn JA; Pereira AM
Psychoneuroendocrinology; 2016 Jan; 63():170-7. PubMed ID: 26454105
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.
Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Ragnarsson O; Skrtic S; Wahlberg J; Achenbach H; Uddin S; Marelli C; Johannsson G
Eur J Endocrinol; 2017 Jun; 176(6):715-725. PubMed ID: 28292927
[TBL] [Abstract][Full Text] [Related]
18. Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study.
Hasenmajer V; Ferrari D; De Alcubierre D; Sada V; Puliani G; Bonaventura I; Minnetti M; Tomaselli A; Pofi R; Sbardella E; Cozzolino A; Gianfrilli D; Isidori AM
J Endocr Soc; 2023 Dec; 8(1):bvad151. PubMed ID: 38090230
[TBL] [Abstract][Full Text] [Related]
19. What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study.
Puglisi S; Rossini A; Tabaro I; Cannavò S; Ferrau' F; Ragonese M; Borretta G; Pellegrino M; Dughera F; Parisi A; Latina A; Pia A; Terzolo M; Reimondo G
J Endocrinol Invest; 2021 Apr; 44(4):865-872. PubMed ID: 32779106
[TBL] [Abstract][Full Text] [Related]
20. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
